A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Recruiting · NCT06311578 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors | neoplasm | Recruiting | Phase 1 | 2026-09-25 | NCT06311578 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Johnson & Johnson Enterprise Innovation Inc. | 6 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier de l'Universite de Montreal | Montreal | Canada | 11 |
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| Gustave Roussy | Villejuif | France | 119 |
| Hosp Univ Fund Jimenez Diaz | Madrid | Spain | 33 |
| Hosp Univ Hm Sanchinarro | Madrid | Spain | 17 |
| Hosp Univ Vall D Hebron | Barcelona | Spain | 46 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| NYU Langone Health | New York | United States | 403 |
| Toronto General Hospital | Toronto | Canada | 42 |
| UPMC Cancer Centers | Pittsburgh | United States | 2 |